This page shows the latest brain news and features for those working in and with pharma, biotech and healthcare.
In people with MS, inflammatory immune cells such as lymphocytes can cross the blood brain barrier into the brain, damaging the protective sheath that insulates nerve cells – known as myelin.
of clots in the vessels draining blood from the brain (CVST).
In people with MS, inflammatory immune cells such as lymphocytes can cross the blood brain barrier into the brain, damaging the protective sheath that insulates nerve cells – known as myelin. ... Janssen's drug also showed statistically signifiant
J&J’s drug also outperformed Aubagio on fatigue scores, MRI assessments of the number of active lesions in the brain and the time to confirmed disability accumulation (CDA) – a measure
of clots in the vessels draining blood from the brain (CVST).
Although newly reported findings for secondary outcomes within this trial ‘showed no substantial difference’, Lilly highlighted exploratory analyses that showed donanemab slowed the accumulation of tau across key brain regions in
More from news
Approximately 3 fully matching, plus 616 partially matching documents found.
levels, stress levels, breathing rate, and even different types of brain activity in real time.
construct a device to deliver the therapy to precise areas of the brain in the hope of regenerating dying dopamine cells.
Our brains react differently to seeing faces and hearing voices and these can help achieve more meaningful interactions.
Ongoing brain development can pose as a threat to adherence. Not only do adolescents have underdeveloped impulse control that may be associated with rebellion against a healthcare provider or parental advice,
Due to the way their brains work and the impact of peer pressure, teenagers can struggle to weigh up the rational consequences of their actions in the heat of the moment.
More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.
His outstanding track record and expertise in neurodegenerative disease are crucial as we are about to progress our first highly brain penetrant and orally bioavailable tau modifier into the clinic for
In particular, their experience as co-founders of Polleo will be invaluable as we advance our behavioural brain disease portfolio.”.
He is currently an adjunct full professor of UCLA's department of psychiatry and biobehavioural sciences and a member of the Brain Research Institute at the David Geffen School of Medicine ... at the RIKEN Brain Science Institute.
The firm focuses on brain health, memory and ageing and its lead product is an oral amyloid aggregation inhibitor that targets Alzheimer's disease.
Ovid is a privately-held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Annually, 2 April is Autism Awareness Day. Being autistic does not mean you have an illness or disease; it means your brain works in a different way from other people.
group”. Nevertheless, there are green shoots of hope for the future of brain tumour research. ... Their research could find more effective ways of treating patients, including children, who suffer from brain tumours.
Changes to the mind and body can mean that women no longer feel ‘like themselves’ alongside experiencing debilitating brain fog and even spells of depression. ... find out, what it does to our brain. Front Neurosci. 2014; 8.
Mikko joins Wilmington Healthcare from the Brain Tumour Charity where, as Head of Digital, he led a team responsible for delivering digital marketing and communications plans across the organisation for income
This shortfall in money will mean that they will not be able to fund as many PhD and postdoctoral positions in the future – leading to a brain drain in the field.
More from PMHub
Approximately 3 fully matching, plus 84 partially matching documents found.
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....